Breaking New Ground in Obesity Therapeutics From Novel Mechanisms to Patient-Centric Solutions
- Expanding the therapeutic arsenal to target neuronal and metabolic pathways for more effective obesity treatments
- Demonstrating superior fat-loss preservation and GI tolerability in next-gen incretin therapies with brain-specific mechanisms to enable personalised obesity treatment
- Innovating delivery systems from DNA-encoded therapies to oral formulations for sustained peptide delivery